⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Boston Biodevelopment, LLC and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Boston Biodevelopment, LLC
↗Boston, MA, USA
Boston Biodevelopment is a premium boutique regulatory strategy consulting firm founded in 2009. The company provides hands-on regulatory leadership and management to small and mid-size life sciences companies throughout the product development and approval lifecycle.
They are known for embedding experienced regulatory professionals into client teams to ensure strategic continuity, particularly during times of transition or growth. Their expertise spans a wide range of modalities, including biologics, small molecules, cell and gene therapies, and gene editing products.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Founded:2009
Ownership:private
Status:operating
PIPELINE
Modalities:Small molecule, Biologics, Cell therapy, Gene therapy, Gene editing
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Small and mid-size biopharma companies (clients)
COMPETITION
Position:Niche Player
Competitors:ADVI Health, BioTechLogic, Dark Horse Consulting, Lumanity
LEADERSHIP
Key Executives:
Helena Correia - Founder & CEO
Angela L. Nelson - EVP & Partner, Chief Strategy Officer
LINKS
Website:bostonbiodevelopment.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Boston Biodevelopment, LLC. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.